Therapie

Papers
(The H4-Index of Therapie is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Uses of pharmacovigilance databases: An overview104
Pharmacovigilance and drug safety: Fair prescribing and clinical research53
Safety data and withdrawal of hepatotoxic drugs53
Long-term use of proton pump inhibitors as a risk factor for various adverse manifestations46
Management of drug-drug interactions with nirmatrelvir/ritonavir in patients treated for Covid-19: Guidelines from the French Society of Pharmacology and Therapeutics (SFPT)39
Efficacy of COVID-19 vaccines: From clinical trials to real life31
Atypical thrombosis associated with VaxZevria® (AstraZeneca) vaccine: Data from the French Network of Regional Pharmacovigilance Centres25
French organization for the pharmacovigilance of COVID-19 vaccines: A major challenge23
Type I interferons as the potential mechanism linking mRNA COVID-19 vaccines to Bell's palsy22
Peptides-based therapeutics: Emerging potential therapeutic agents for COVID-1918
Skin cancers under Janus kinase inhibitors: A World Health Organization drug safety database analysis17
Reappraisal of the efficacy of intensive glycaemic control on microvascular complications in patients with type 2 diabetes: A meta-analysis of randomised control-trials14
Drug prescriptions in French pregnant women between 2015 and 2016: A study in the EGB database13
0.22958993911743